Page last updated: 2024-11-05

thallium nitrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID24937
MeSH IDM0124673

Synonyms (31)

Synonym
thallium nitrate
thallium(1+) nitrate
thallous nitrate
nitric acid, thallium(1+) salt
thallium mononitrate
thalliumi) nitrate
thallium(1)nitrate
thallium(i) nitrate
nsc 84275
thallium (i) nitrate
thallium nitrate (van)
einecs 233-273-1
un2727
hsdb 6067
rcra waste number u217
rcra waste no. u217
ljq38dsr12 ,
unii-ljq38dsr12
thallium nitrate [un2727] [poison]
tox21_200256
dtxsid1024334 ,
dtxcid504334
NCGC00257810-01
cas-10102-45-1
nitric acid, thallium salt
16901-76-1
AKOS025293959
thallium mononitrate [mi]
thallous nitrate [hsdb]
FYWSTUCDSVYLPV-UHFFFAOYSA-N
mfcd00011280

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The results clearly show that Tl(III) is extremely toxic to daphnids."( Acute toxicity of trivalent thallium compounds to Daphnia magna.
Lan, CH; Lin, TS, 2005
)
0.33
"We studied action of inorganic phosphate (P(i)) on toxic effects of Tl+ in isolated rat liver mitochondria."( Inorganic phosphate stimulates the toxic effects of Tl+ in rat liver mitochondria.
Emel'yanova, LV; Korotkov, SM; Yagodina, OV,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.00250.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency21.57010.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency47.61890.000221.22318,912.5098AID743035; AID743040; AID743054; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency61.56600.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency61.97450.001022.650876.6163AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency30.85610.000417.946075.1148AID1346795
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency34.22780.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.39190.000229.305416,493.5996AID743075
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency69.07820.001723.839378.1014AID743083
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency69.07820.000323.4451159.6830AID743065; AID743067
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.35 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.09 (4.65)
Search Engine Demand Index66.70 (26.88)
Search Engine Supply Index1.89 (0.95)

This Compound (48.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]